Project Grant HT94252510291
Award Date
6/15/25
Completion Date
6/14/28
Dollars Obligated
$981K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Memphis, TN 38105, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,295,000.00 to St. Jude Children's Research Hospital Inc. to conduct research aimed at creating cures for patients with Langerhans cell histiocytosis. The award period runs from September 1, 2024 to August 31, 2028. This research project builds upon St. Jude's extensive experience in pediatric cancer and other life-threatening diseases in...
This Project Grant award for $1,340,665.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to St. Jude Children's Research Hospital Inc. The award supports research focused on the FGFR pathway as a lead therapeutic vulnerability in pediatric ependymoma, a type of brain cancer in children. The project will be conducted over 3 years, from September 1, 2023 to August 31, 2026, and aims to advance the development of effective...
The Defense Health Agency awarded a $1,294,957 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to St. Jude Children's Research Hospital Inc. The grant, titled "CONQUER: CAR T-CELL LONG-TERM FOLLOW-UP, QUALITY OF LIFE, AND ADVERSE REACTIONS," will fund research focused on developing and evaluating CAR T-cell therapies for pediatric patients. The grant period runs from July 1, 2024 to June 30, 2028. The grant involves two sub-awards. One...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $591,248 Project Grant to St. Jude Children's Research Hospital Inc. to conduct research on "SMARCAL1: A UNIQUE TARGET IN ALT-POSITIVE PEDIATRIC SOLID TUMORS." The project will run from September 30, 2024 to September 29, 2026. As part of this grant, St. Jude Children's Research Hospital Inc. will be collaborating with Icahn School of Medicine at Mount Sinai as a...
The Defense Health Agency awarded a $1,528,727.00 Project Grant to Children's Research Institute, a subsidiary of Children's National Medical Center, to develop SGT-53, a novel nanomedicine that crosses the blood-brain barrier and augments immunotherapeutic response in pediatric brain cancers. This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the...
The Department of the Army Medical Command awarded a $1,416,000 project grant to Boston Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to define leukemia stem cells in acute lymphoblastic leukemia from September 2021 through September 2025. Through this funding, Boston Children's Hospital researchers will investigate medical solutions for the battlefield by transforming healthcare for service members and the public. The...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The Defense Health Agency awarded a $390,000 Project Grant to the Sanford Burnham Prebys Medical Discovery Institute to support research using systems genetics to probe for gene interactions in congenital heart disease. The two-year award, made under the Military Medical Research and Development program (CFDA 12.420), will fund work from February 2021 through August 2023. The Military Medical Research and Development program aims to transform military and public health through innovative...
The Children's Research Institute received a $709,638 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research efforts from May 2021 through April 2024 to enhance T-cell immunotherapy treatments for pediatric patients with relapsed or refractory solid tumors. The Military Medical Research and Development program supports biomedical research that transforms military and public health...
This $1,354,428 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a family-centered e-health intervention to promote patient and caregiver well-being in adolescent and emerging adult pediatric brain tumor survivors. The grant was awarded to the Children's Hospital Medical Center in Cincinnati, Ohio, which will serve as the prime awardee. The project duration is from September 1, 2024 to August 31, 2028. The...